Men taking hormones to control prostate cancer need to be monitored and treated for osteoporosis, a new study says.Although osteoporosis is most often associated with postmenopausal women, men also lose bone density as they age. And for men with prostate cancer, one of the most common therapies can speed up bone mineral loss and lead to osteoporosis and bone fractures, the new research confirms.
